Medtronic (MDT) announced the appointment of Chad Spooner as chief financial officer, CFO, of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent. Most recently, Spooner served as CFO at BIC
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- KKR, Medtronic, Disney, Circle, Barrick: Trending by Analysts
- Medtronic’s Loop Recorder Study: A Potential Game-Changer in Cardiac Diagnostics
- Medtronic’s Care-HF Study: A Milestone in Cardiac Resynchronization Therapy
- Medtronic’s CORE Study Update: Evaluating the Conducted AF-Response Algorithm
- Medtronic’s ICD Study: A Step Forward in Cardiac Care